Charlotte Guldborg Nyvold

Precise quantification of minimal residual disease at day 29 allows identification of children with acute lymphoblastic leukemia and an excellent outcome

Charlotte Guldborg Nyvold, Hans O. Madsen, Lars P. Ryder et al. · Blood · 2002 · 157 citations · Full text

Harmonization of BCR-ABL mRNA quantification using a uniform multifunctional control plasmid in 37 international laboratories

Martin C. Müller, Philipp Erben, Giuseppe Saglio et al. · Leukemia · 2007 · 107 citations

International Laboratories, Functional Genomics, Molecular Biological Method +10

Chimeric Antigen Receptor T Cells Targeting CD79b Show Efficacy in Lymphoma with or without Cotargeting CD19

Maria Ormhøj, Irene Scarfò, Maria L. Cabral et al. · Clinical Cancer Research · 2019 · 80 citations · Full text

Relapse prediction in acute myeloid leukaemia patients in complete remission using <i>WT1</i> as a molecular marker: development of a mathematical model to predict time from molecular to clinical relapse and define optimal sampling intervals

Hans Beier Ommen, Charlotte Guldborg Nyvold, Karin Brændstrup et al. · British Journal of Haematology · 2008 · 73 citations · Full text

Human intestinal P‐glycoprotein activity estimated by the model substrate digoxin

Ulla Lei Larsen, Hyldahl L. Olesen, Charlotte Guldborg Nyvold et al. · Scandinavian Journal of Clinical and Laboratory Investigation · 2006 · 59 citations